Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway FASEB J. Marsche et al.
21: 1145
Supplemental Data
Files in this Data Supplement:
Supplemental Data -
(06-7439SuppData.pdf; 419 KB) Text:Characterization of modified albumin preparations. Table I: Amino acid analyses of albumin preparations. Figure I: Characterization of HOCl-albumin and AGE-albumin. Figure II: Blocking of HOCl-albumin binding by anti-sRAGE IgG.